alexa Pharmacovigilance Major Problem Is Counterfeit Drugs
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
November 18-19, 2013 Hilton San Antonio Airport, TX, USA

Sravankumar Gunda
ScientificTracks Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.007
All countries around the world have an up growing major problem- counterfeit drugs. The present study has information about how to identify counterfeit drugs in drug supply chain and get 100% accurate data for pharmacovigilance. Most of the pharma companies are data basing the reports from various sources like hospitals, patients, physicians, patient support program and etc. Recent problems noticed by companies were, reports from patients coming due to lack of efficacy as they are using counterfeit drugs. Most of the counterfeit drugs are produced from developing countries like India and China. In recent years, all the big pharma companies like Merck, Eli lilly, Ranbaxy, Pzifer, Johnson & Johnson and GlaxoSmithKline alone paid about $13 billons as penalties to different regulatory authorities. This money paid as fine could be used for more clinical studies for development of new drugs. Information about factors encouraging counterfeit drugs and how counterfeit dugs are affecting pharmacovigilance and measures taken to eradicate this problem were mentioned. World health organisation plays a key role in eradication of counterfeit drugs. UK and US had very strong network on controlling counterfeit drugs, and MHRA was one of the development by UK government and USFDA also has very strict rules and procedures to be followed for drugs import in US. Unique Identification Code (UIC) would be one of the measure for getting accurate data from patient or any other source about the company genuine drug. UIC would be most economical technique used in identification of counterfeit drugs in developing countries during drug supply chain. Fake drugs generally resemble like genuine drugs but their percentage of active constituents is always question mark. Because of this reason most of the lack of effect cases is noted in pharmacovigilance. Procedures and methods to be followed to get accurate safety data from patient and other sources. Development in facilities provided to the patient (like toll free no, web email, text services) while reporting a complaint against a company drug. Collecting samples of the company drug from the patient once a complaint was lodged due to lack of effect will make company to be sure about manufacturing defect or supply chain or because of counterfeited drug. Governments and regulatory board of different countries are taking certain steps against companies by increasing penalties and imprisonment duration. So, relentless efforts should be made in developing methods in identification of counterfeit drugs and funds should be increased for R&D, so that 100% accurate data will be recorded in pharmacovigilance.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version